Teladoc Health (TDOC) Stock Forecast, Price Target & Predictions
TDOC Stock Forecast
Teladoc Health stock forecast is as follows: an average price target of $52.65 (represents a 477.94% upside from TDOC’s last price of $9.11) and a rating consensus of 'Hold', based on 21 wall street analysts offering a 1-year stock forecast.
TDOC Price Target
TDOC Analyst Ratings
Teladoc Health Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Aug 06, 2024 | Jessica Tassan | Piper Sandler | $10.00 | $7.60 | 31.58% | 9.77% |
Jun 11, 2024 | Steve Valiquette | Barclays | $20.00 | $10.48 | 90.75% | 119.54% |
May 31, 2024 | Glen Santangelo | Jefferies | $10.00 | $11.29 | -11.43% | 9.77% |
May 20, 2024 | Glen Santangelo | Jefferies | $14.00 | $12.39 | 12.99% | 53.68% |
Apr 05, 2024 | George Hill | Deutsche Bank | $18.00 | $14.64 | 22.91% | 97.59% |
Apr 12, 2023 | Jeff Garro | Stephens | $25.00 | $25.86 | -3.33% | 174.42% |
Dec 13, 2022 | - | Citigroup | $33.00 | $27.63 | 19.44% | 262.24% |
Sep 28, 2022 | - | RBC Capital | $35.00 | $27.52 | 27.18% | 284.19% |
Sep 27, 2022 | - | Deutsche Bank | $31.00 | $26.37 | 17.56% | 240.29% |
Jul 31, 2022 | Steve Valiquette | Barclays | $42.00 | $36.85 | 13.98% | 361.03% |
Teladoc Health Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 1 | 5 |
Avg Price Target | - | $10.00 | $14.40 |
Last Closing Price | $9.11 | $9.11 | $9.11 |
Upside/Downside | -100.00% | 9.77% | 58.07% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Sep 17, 2024 | Jefferies | Buy | Buy | Hold |
Sep 17, 2024 | Jefferies | Hold | Hold | Hold |
Aug 20, 2024 | Piper Sandler | Buy | Buy | Hold |
Aug 20, 2024 | Oppenheimer | Underperform | Underperform | Hold |
Aug 06, 2024 | Piper Sandler | Mixed | Mixed | Hold |
Aug 06, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Jun 11, 2024 | Barclays | Overweight | Overweight | Hold |
Jun 11, 2024 | Bank of America Securities | Neutral | Neutral | Hold |
Jun 10, 2024 | Citigroup | Neutral | Neutral | Hold |
May 20, 2024 | Jefferies | Hold | Hold | Hold |
Teladoc Health Financial Forecast
Teladoc Health Revenue Forecast
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $660.24M | $652.41M | $629.24M | $637.71M | $611.40M | - | $565.35M | $554.24M | $521.66M | $503.14M | $453.68M | $383.32M | $288.81M |
Avg Forecast | $786.92M | $768.01M | $752.18M | $735.73M | $654.93M | $645.56M | $645.79M | $645.83M | $643.13M | $632.93M | $631.38M | $633.72M | $633.14M | $630.95M | $649.16M | $637.31M | $670.81M | $663.54M | $649.18M | $619.30M | $633.40M | $608.89M | $586.74M | $568.68M | $547.17M | $516.63M | $500.60M | $451.91M | $378.93M | $282.18M |
High Forecast | $814.33M | $794.77M | $778.38M | $761.36M | $677.74M | $668.05M | $668.28M | $668.32M | $665.54M | $654.98M | $653.37M | $655.80M | $655.20M | $649.06M | $671.78M | $659.51M | $675.14M | $674.54M | $671.80M | $640.87M | $655.47M | $630.11M | $586.74M | $582.89M | $560.85M | $529.54M | $513.12M | $463.21M | $388.41M | $289.24M |
Low Forecast | $772.13M | $753.58M | $738.04M | $721.90M | $642.62M | $633.42M | $633.65M | $633.69M | $631.05M | $621.03M | $619.51M | $621.81M | $621.24M | $621.72M | $636.96M | $625.33M | $667.50M | $656.16M | $636.98M | $607.66M | $621.50M | $597.45M | $586.74M | $554.47M | $533.50M | $503.72M | $488.10M | $440.63M | $369.47M | $275.13M |
# Analysts | 8 | 10 | 16 | 8 | 8 | 8 | 12 | 8 | 12 | 7 | 7 | 13 | 9 | 17 | 8 | 10 | 11 | 22 | 11 | 11 | 16 | 10 | 11 | 19 | 11 | 14 | 11 | 7 | 7 | 8 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.00% | 1.00% | 1.02% | 1.01% | 1.00% | - | 0.99% | 1.01% | 1.01% | 1.01% | 1.00% | 1.01% | 1.02% |
Teladoc Health EBITDA Forecast
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 8 | 10 | 16 | 8 | 8 | 8 | 12 | 8 | 12 | 7 | 7 | 13 | 9 | 17 | 8 | 10 | 11 | 22 | 11 | 11 | 16 | 10 | 11 | 19 | 11 | 14 | 11 | 7 | 7 | 8 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $40.39M | $31.15M | $24.51M | $3.83B | $-6.27M | - | $-1.27M | $19.75M | $-1.54M | $-12.22M | $-20.27M | $-360.90M | $18.60M |
Avg Forecast | $110.75M | $108.09M | $105.86M | $103.55M | $92.18M | $90.86M | $90.89M | $90.89M | $90.52M | $89.08M | $88.86M | $89.19M | $89.11M | $88.80M | $91.36M | $-375.52B | $94.41M | $93.39M | $91.37M | $-401.62B | $89.15M | $-8.77M | $82.58M | $-429.54B | $25.61M | $-7.97M | $-32.85M | $-35.76M | $-4.07B | $-3.66M |
High Forecast | $114.61M | $111.86M | $109.55M | $107.15M | $95.39M | $94.02M | $94.06M | $94.06M | $93.67M | $92.18M | $91.96M | $92.30M | $92.21M | $91.35M | $94.55M | $-300.41B | $95.02M | $94.94M | $94.55M | $-321.30B | $92.25M | $-7.02M | $82.58M | $-343.63B | $30.73M | $-6.38M | $-26.28M | $-28.61M | $-3.25B | $-2.93M |
Low Forecast | $108.67M | $106.06M | $103.87M | $101.60M | $90.44M | $89.15M | $89.18M | $89.19M | $88.81M | $87.41M | $87.19M | $87.51M | $87.43M | $87.50M | $89.65M | $-450.62B | $93.94M | $92.35M | $89.65M | $-481.94B | $87.47M | $-10.53M | $82.58M | $-515.45B | $20.49M | $-9.57M | $-39.42M | $-42.91M | $-4.88B | $-4.39M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.43% | 0.34% | -0.00% | 42.96% | 0.72% | - | 0.00% | 0.77% | 0.19% | 0.37% | 0.57% | 0.09% | -5.08% |
Teladoc Health Net Income Forecast
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 8 | 10 | 16 | 8 | 8 | 8 | 12 | 8 | 12 | 7 | 7 | 13 | 9 | 17 | 8 | 10 | 11 | 22 | 11 | 11 | 16 | 10 | 11 | 19 | 11 | 14 | 11 | 7 | 7 | 8 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-57.07M | $-65.18M | $-69.23M | $-3.81B | $-73.48M | - | $-6.67B | $-10.98M | $-84.34M | $-133.82M | $-199.65M | $-393.97M | $-35.88M |
Avg Forecast | $30.64M | $-17.02M | $-34.05M | $-45.96M | $-25.23M | $-41.55M | $-44.50M | $-58.31M | $-17.61M | $-38.64M | $-41.74M | $-54.73M | $-26.58M | $-45.72M | $-58.66M | $-379.42B | $-37.33M | $-62.05M | $-69.19M | $-405.80B | $-41.87M | $-109.90M | $-102.49M | $-434.01B | $-18.54M | $-99.91M | $-79.84M | $-187.60M | $-3.83B | $-23.55M |
High Forecast | $32.03M | $-16.61M | $-33.21M | $-44.84M | $-24.62M | $-40.53M | $-43.41M | $-56.88M | $-17.18M | $-37.70M | $-40.72M | $-53.39M | $-25.93M | $-20.49M | $-57.23M | $-303.54B | $27.15M | $-45.28M | $-67.50M | $-324.64B | $-40.84M | $-87.92M | $-102.49M | $-347.21B | $-14.83M | $-79.93M | $-63.87M | $-150.08M | $-3.06B | $-18.84M |
Low Forecast | $29.89M | $-17.79M | $-35.59M | $-48.04M | $-26.37M | $-43.43M | $-46.52M | $-60.95M | $-18.41M | $-40.39M | $-43.63M | $-57.21M | $-27.78M | $-55.17M | $-61.32M | $-455.31B | $-49.20M | $-77.14M | $-72.33M | $-486.96B | $-43.76M | $-131.88M | $-102.49M | $-520.81B | $-22.24M | $-119.89M | $-95.81M | $-225.12M | $-4.59B | $-28.26M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.92% | 0.94% | 0.00% | 91.00% | 0.67% | - | 0.02% | 0.59% | 0.84% | 1.68% | 1.06% | 0.10% | 1.52% |
Teladoc Health SG&A Forecast
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 8 | 10 | 16 | 8 | 8 | 8 | 12 | 8 | 12 | 7 | 7 | 13 | 9 | 17 | 8 | 10 | 11 | 22 | 11 | 11 | 16 | 10 | 11 | 19 | 11 | 14 | 11 | 7 | 7 | 8 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $301.87M | $358.13M | $345.43M | $322.57M | $346.10M | - | $296.85M | $290.92M | $276.70M | $278.29M | $259.40M | $531.68M | $135.53M |
Avg Forecast | $477.35M | $465.88M | $456.28M | $446.30M | $397.28M | $391.60M | $391.74M | $391.76M | $390.13M | $383.94M | $383.00M | $384.42M | $384.07M | $382.74M | $393.79M | $386.60M | $406.92M | $402.50M | $393.80M | $375.67M | $384.23M | $360.56M | $355.92M | $344.96M | $490.93M | $327.78M | $166.03M | $243.75M | $229.86M | $88.94M |
High Forecast | $493.98M | $482.11M | $472.17M | $461.84M | $411.12M | $405.24M | $405.38M | $405.41M | $403.72M | $397.31M | $396.34M | $397.81M | $397.45M | $393.72M | $407.50M | $400.06M | $409.54M | $409.18M | $407.52M | $388.76M | $397.61M | $432.67M | $355.92M | $353.59M | $589.12M | $393.33M | $199.24M | $292.50M | $235.61M | $106.73M |
Low Forecast | $468.38M | $457.12M | $447.70M | $437.91M | $389.81M | $384.24M | $384.37M | $384.40M | $382.80M | $376.72M | $375.80M | $377.19M | $376.85M | $377.14M | $386.38M | $379.33M | $404.91M | $398.03M | $386.40M | $368.61M | $377.00M | $288.44M | $355.92M | $336.35M | $392.74M | $262.22M | $132.83M | $195.00M | $224.12M | $71.15M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.75% | 0.91% | 0.92% | 0.84% | 0.96% | - | 0.86% | 0.59% | 0.84% | 1.68% | 1.06% | 2.31% | 1.52% |
Teladoc Health EPS Forecast
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 8 | 10 | 16 | 8 | 8 | 8 | 12 | 8 | 12 | 7 | 7 | 13 | 9 | 17 | 8 | 10 | 11 | 22 | 11 | 11 | 16 | 10 | 11 | 19 | 11 | 14 | 11 | 7 | 7 | 8 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.35 | $-0.40 | $-0.42 | $-23.49 | $-0.45 | - | $-41.58 | $-0.07 | $-0.53 | $-0.86 | $-1.31 | $-3.07 | $-0.43 |
Avg Forecast | $0.18 | $-0.10 | $-0.20 | $-0.27 | $-0.15 | $-0.24 | $-0.26 | $-0.34 | $-0.10 | $-0.23 | $-0.25 | $-0.32 | $-0.16 | $-0.27 | $-0.34 | $-0.46 | $-0.22 | $-0.36 | $-0.41 | $-0.48 | $-0.25 | $-0.57 | $-0.61 | $-0.60 | $-0.57 | $-0.67 | $-0.53 | $-0.54 | $-0.26 | $-0.32 |
High Forecast | $0.19 | $-0.10 | $-0.20 | $-0.26 | $-0.14 | $-0.24 | $-0.26 | $-0.33 | $-0.10 | $-0.22 | $-0.24 | $-0.31 | $-0.15 | $-0.12 | $-0.34 | $-0.45 | $0.16 | $-0.27 | $-0.40 | $-0.47 | $-0.24 | $-0.55 | $-0.61 | $-0.58 | $-0.55 | $-0.65 | $-0.51 | $-0.52 | $-0.25 | $-0.31 |
Low Forecast | $0.18 | $-0.10 | $-0.21 | $-0.28 | $-0.15 | $-0.26 | $-0.27 | $-0.36 | $-0.11 | $-0.24 | $-0.26 | $-0.34 | $-0.16 | $-0.32 | $-0.36 | $-0.48 | $-0.29 | $-0.45 | $-0.42 | $-0.51 | $-0.26 | $-0.59 | $-0.61 | $-0.62 | $-0.59 | $-0.69 | $-0.55 | $-0.56 | $-0.27 | $-0.33 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.96% | 0.98% | 0.87% | 95.51% | 0.80% | - | 69.43% | 0.12% | 0.79% | 1.63% | 2.42% | 11.82% | 1.34% |
Teladoc Health Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
TDOC | Teladoc Health | $9.11 | $52.65 | 477.94% | Hold |
ACCD | Accolade | $4.31 | $14.81 | 243.62% | Buy |
GDRX | GoodRx | $7.59 | $14.57 | 91.96% | Buy |
TXG | 10x Genomics | $21.41 | $30.20 | 41.06% | Hold |
SDGR | Schrödinger | $19.62 | $27.33 | 39.30% | Buy |
PGNY | Progyny | $24.82 | $34.50 | 39.00% | Hold |
TALK | Talkspace | $2.17 | $2.50 | 15.21% | Hold |
GEHC | GE HealthCare | $86.79 | $93.88 | 8.17% | Buy |
VEEV | Veeva Systems | $214.80 | $229.50 | 6.84% | Buy |
DOCS | Doximity | $40.16 | $32.17 | -19.90% | Buy |
TDOC Forecast FAQ
Is Teladoc Health a good buy?
No, according to 21 Wall Street analysts, Teladoc Health (TDOC) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 10 'Buy' recommendations, accounting for 47.62% of TDOC's total ratings.
What is TDOC's price target?
Teladoc Health (TDOC) average price target is $52.65 with a range of $10 to $150, implying a 477.94% from its last price of $9.11. The data is based on 21 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Teladoc Health stock go up soon?
According to Wall Street analysts' prediction for TDOC stock, the company can go up by 477.94% (from the last price of $9.11 to the average price target of $52.65), up by 1546.54% based on the highest stock price target, and up by 9.77% based on the lowest stock price target.
Can Teladoc Health stock reach $14?
TDOC's average twelve months analyst stock price target of $52.65 supports the claim that Teladoc Health can reach $14 in the near future.
What are Teladoc Health's analysts' financial forecasts?
Teladoc Health's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $2.59B (high $2.68B, low $2.54B), average EBITDA is $364.82M (high $377.52M, low $357.96M), average net income is $-170M (high $-165M, low $-177M), average SG&A $1.57B (high $1.63B, low $1.54B), and average EPS is $-0.996 (high $-0.972, low $-1.041). TDOC's analysts financial forecasts for the fiscal year (Dec 2027) are as follows: average revenue is $3.04B (high $3.15B, low $2.99B), average EBITDA is $428.25M (high $443.17M, low $420.2M), average net income is $-66.39M (high $-62.63M, low $-71.534M), average SG&A $1.85B (high $1.91B, low $1.81B), and average EPS is $-0.39 (high $-0.368, low $-0.42).
Did the TDOC's actual financial results beat the analysts' financial forecasts?
Based on Teladoc Health's last annual report (Dec 2022), the company's revenue was $2.41B, beating the average analysts forecast of $2.4B by 0.38%. Apple's EBITDA was $13.47B, missing the average prediction of $-429B by -103.14%. The company's net income was $-13.66B, missing the average estimation of $-434B by -96.85%. Apple's SG&A was $1.3B, missing the average forecast of $1.45B by -10.04%. Lastly, the company's EPS was $-84.6, beating the average prediction of $-2.021 by 4085.59%. In terms of the last quarterly report (Sep 2023), Teladoc Health's revenue was $660.24M, missing the average analysts' forecast of $663.54M by -0.50%. The company's EBITDA was $40.39M, missing the average prediction of $93.39M by -56.75%. Teladoc Health's net income was $-57.073M, missing the average estimation of $-62.05M by -8.02%. The company's SG&A was $301.87M, missing the average forecast of $402.5M by -25.00%. Lastly, the company's EPS was $-0.35, missing the average prediction of $-0.365 by -3.98%